Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
03/1991
03/13/1991EP0416393A1 Peptidyl difluorodiol renin inhibitors
03/13/1991EP0416373A2 Amino acid derivatives
03/13/1991EP0416029A1 Procalcitonin peptides
03/13/1991EP0403600A4 Deprotection of protected peptides
03/13/1991EP0394326A4 Conformationally stabilized cell adhesion peptides
03/13/1991EP0379534A4 Method of purifying cross-linked hemoglobin
03/13/1991EP0185762B1 Cell-delivery agent
03/12/1991WO1991004267A1 A method for the purification of transforming growth factor (tgf-)
03/12/1991US4999422 Continuous method of refolding proteins
03/12/1991US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
03/12/1991CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA2023595A1 Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy
03/12/1991CA1281500C2 Bifunctional chelating agents
03/12/1991CA1281499C2 Bifunctional chelating agents
03/12/1991CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters
03/08/1991CA2024782A1 High molecular weight protein/fatty acid condensation products which are very well tolerated by the skin and mucosa
03/08/1991CA2024697A1 Protein having anticoagulant properties
03/08/1991CA2005917A1 Method for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography
03/07/1991WO1991002978A1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002790A1 Enzymes which participate in c-terminal amidation, and production and use thereof
03/07/1991WO1991002789A1 Treatment of immobilized matrices with antimicrobial agents to remove pyrogen-producing organisms and pyrogens
03/07/1991WO1991002753A1 Anticoagulant protein
03/07/1991WO1991002714A1 Automated peptide design and synthesis
03/07/1991WO1991002537A1 Synthetic peptides that enhance cell binding
03/07/1991WO1990014844A3 Sugars as cleavable linkers for the delivery and release of agents in native form
03/07/1991CA2039174A1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof
03/07/1991CA2024701A1 Process for the purification of plasminogen activator inhibitor 2 (pai-2)
03/06/1991EP0415902A1 Oxy- or thio-substituted fatty acid analogs for use in the treatment of retroviral infections
03/06/1991EP0415801A1 Monoclonal antibodies against activated microglial cells
03/06/1991EP0415557A2 Separation of anti-metal chelate antibodies
03/06/1991EP0415331A2 Allyl esters and their application to the construction of solid phase systems for solid phase reactions
03/06/1991EP0415219A1 ANF-Antagonist
03/06/1991EP0414915A1 New superoxide dismutase
03/06/1991EP0414807A1 Human mammary cell growth inhibitor and methods of production and use
03/06/1991CA2024698A1 Peptidyl diflurodiol renin inhibitors
03/06/1991CA2024598A1 Method for activating protein c
03/05/1991WO1991003487A1 Prodrug derivatives of thyrotropin-releasing hormone (trh)
03/05/1991US4997915 Purification of pertussis toxins
03/05/1991US4997914 Method for separating and purifying lactoferrin from milk by use of sulfuric ester
03/05/1991US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy
03/05/1991CA2066449A1 Prodrug derivatives of thyrotropin-releasing hormone (trh)
03/05/1991CA2024250A1 Method for purifying low molecular weight compounds of peptide of pseudo-peptide structure
03/05/1991CA2023099A1 Amino acid derivatives
03/05/1991CA1280987C Antibacterial composition
03/05/1991CA1280972C Complex immunogen containing synthetic peptides
03/02/1991CA2024489A1 Method of inhibiting virus
03/02/1991CA2024053A1 Anf-antagonist
02/1991
02/27/1991EP0414632A2 Cyclosporin derivatives
02/27/1991EP0414374A2 Novel antigens and methods for their preparation
02/27/1991EP0413967A1 Novel antibiotic
02/27/1991EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it
02/27/1991EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide.
02/27/1991CN1049505A Peptides having bradykinin-antagonistic action
02/26/1991US4996358 Control, prevention rheumatic diseases
02/26/1991US4996159 Purified polypeptides
02/26/1991CA1280693C Purification of pertussis antigens
02/24/1991WO1991002977A1 Wound healing preparations containing heparanase
02/24/1991CA2065744A1 Wound healing preparations containing heparanase
02/21/1991WO1991002058A1 Production of vascular endothelial cell growth factor
02/21/1991WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides
02/21/1991WO1991001976A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same
02/21/1991WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
02/21/1991WO1991001744A2 Uses of interleukin-4 and method for purifying it
02/21/1991DE4006436C1 Refining proteins from crude suspension or soln. - by warming with microwave energy to denature unwanted proteins, used for refining invertase from baker's yeast
02/21/1991CA2064753A1 Uses of interleukin-4 and method for purifying it
02/20/1991EP0413277A1 Peptide antagonists of bradykinin
02/20/1991EP0413209A1 LHRH analogs
02/20/1991EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2
02/20/1991CN1049353A Cyclic neurokinin a antagonists
02/19/1991WO1991002755A1 Fibulin
02/19/1991US4994605 Method of separating alpha-L-aspartyl-L-phenylalanine methyl ester through crystallization
02/19/1991US4994556 Antitumor agents
02/19/1991US4994555 Process for recovery of glycopeptidic antibiotics
02/19/1991US4994554 Probursin
02/19/1991CA2064818A1 Fibulin
02/19/1991CA1280379C Peptides and compositions
02/19/1991CA1280365C Radionuclide antibody coupling
02/13/1991EP0412841A1 Human thrombomodulin derivatives
02/13/1991EP0412542A2 Cyclic neurokinin antagonists
02/13/1991EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use
02/13/1991EP0412466A2 Preparation of a stable factor VIII
02/13/1991EP0412465A1 Process for correct biocatalytic chain folding of denaturated recombinant fusion proteins
02/13/1991EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments
02/13/1991EP0412105A1 Stem cell inhibitors
02/13/1991CN1049164A Aminooligohydroxy derivatives for inhibiting renin and process for preparing same
02/13/1991CN1049106A Stabilized fgf composition and production thereof
02/12/1991WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease
02/12/1991US4992531 Production of proteins in active forms
02/12/1991US4992383 Method for protein and peptide sequencing using derivatized glass supports
02/12/1991US4992369 Fermentation process for glycopeptide antibiotic
02/12/1991US4992271 Formulation for lipophilic IL-2 proteins
02/12/1991US4992178 Inorganic ultrafiltration of microfiltration membrane modified by a hydrophilic polymer, its preparation process and its use for the separation of proteins
02/12/1991CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease
02/12/1991CA2022713A1 Human thrombomodulin derivatives
02/12/1991CA2021880A1 Psycho-pharmacological peptides
02/12/1991CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions
02/09/1991CA2022816A1 Compounds
02/07/1991WO1991001144A1 Labeled polypeptide derivatives